Editorial: Complement and Immunotherapeutics.
作者信息
Okrój Marcin, Volokhina Elena
机构信息
Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland.
Department of Pediatric Nephrology, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands.
出版信息
Front Immunol. 2021 Feb 24;12:663459. doi: 10.3389/fimmu.2021.663459. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Complement and Immunotherapeutics.社论：补体与免疫疗法
Front Immunol. 2021 Feb 24;12:663459. doi: 10.3389/fimmu.2021.663459. eCollection 2021.
2
Disturbances in complement recognition and control in human disease - An editorial to a special issue on "Complement Regulation".人类疾病中补体识别与调控的紊乱——关于“补体调节”特刊的一篇社论
Semin Immunol. 2019 Oct;45:101345. doi: 10.1016/j.smim.2019.101345. Epub 2019 Nov 5.
3
Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing.镰状细胞病与靶向治疗中的补体：我只知道一件事，那就是我一无所知。
Blood Rev. 2021 Jul;48:100805. doi: 10.1016/j.blre.2021.100805. Epub 2021 Jan 21.
4
Editorial: The Role of Complement in Tumors.社论：补体在肿瘤中的作用
Front Immunol. 2020 Feb 11;11:139. doi: 10.3389/fimmu.2020.00139. eCollection 2020.
5
Importance of antibody isotypes in antitumor immunity by monocytes and complement using human-immune tumor models.利用人源化免疫肿瘤模型研究单核细胞和补体通过抗体亚型在抗肿瘤免疫中的作用。
Eur J Immunol. 2021 May;51(5):1218-1233. doi: 10.1002/eji.202048885. Epub 2021 Mar 9.
6
Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab.监测接受利妥昔单抗治疗的 B 细胞恶性肿瘤患者的补体系统状态。
Front Immunol. 2020 Nov 19;11:584509. doi: 10.3389/fimmu.2020.584509. eCollection 2020.
7
Role of complement in graft rejection after organ transplantation.补体在器官移植后移植物排斥反应中的作用。
Transfus Med Rev. 2002 Jul;16(3):251-64. doi: 10.1053/tmrv.2002.33460.
8
Exopolysaccharides isolated from hydrothermal vent bacteria can modulate the complement system.从热液喷口细菌中分离出的胞外多糖可以调节补体系统。
PLoS One. 2014 Apr 15;9(4):e94965. doi: 10.1371/journal.pone.0094965. eCollection 2014.
9
Complement in clinical medicine: Clinical trials, case reports and therapy monitoring.临床医学中的补体：临床试验、病例报告与治疗监测。
Mol Immunol. 2017 Sep;89:10-21. doi: 10.1016/j.molimm.2017.05.013. Epub 2017 May 31.
10
Diseases of complement dysregulation-an overview.补体调控异常相关疾病概述。
Semin Immunopathol. 2018 Jan;40(1):49-64. doi: 10.1007/s00281-017-0663-8. Epub 2018 Jan 11.
本文引用的文献
1
Complementopathies and precision medicine.补体系统相关疾病与精准医学
J Clin Invest. 2020 May 1;130(5):2152-2163. doi: 10.1172/JCI136094.
2
The renaissance of complement therapeutics.补体疗法的复兴。
Nat Rev Nephrol. 2018 Jan;14(1):26-47. doi: 10.1038/nrneph.2017.156. Epub 2017 Dec 4.
3
Complement in cancer: untangling an intricate relationship.补体系统在癌症中的作用：揭示复杂关系。
Nat Rev Immunol. 2018 Jan;18(1):5-18. doi: 10.1038/nri.2017.97. Epub 2017 Sep 18.
4
Applying complement therapeutics to rare diseases.将补体疗法应用于罕见病。
Clin Immunol. 2015 Dec;161(2):225-40. doi: 10.1016/j.clim.2015.08.009. Epub 2015 Sep 1.
5
Complement: a key system for immune surveillance and homeostasis.补体：免疫监视和稳态的关键系统。
Nat Immunol. 2010 Sep;11(9):785-97. doi: 10.1038/ni.1923. Epub 2010 Aug 19.
6
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.用于治疗阵发性夜间血红蛋白尿的补体抑制剂依库珠单抗的发现与研发。
Nat Biotechnol. 2007 Nov;25(11):1256-64. doi: 10.1038/nbt1344.
Zotero 插件